A Biomimetic Coordination Nanoplatform for Controlled Encapsulation and Delivery of Drug–Gene Combinations
Dr. Bei Liu
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190 China
Search for more papers by this authorFeng Hu
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190 China
Search for more papers by this authorJingfang Zhang
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190 China
Search for more papers by this authorCongli Wang
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190 China
Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049 China
Search for more papers by this authorCorresponding Author
Prof. Lele Li
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190 China
Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049 China
Search for more papers by this authorDr. Bei Liu
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190 China
Search for more papers by this authorFeng Hu
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190 China
Search for more papers by this authorJingfang Zhang
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190 China
Search for more papers by this authorCongli Wang
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190 China
Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049 China
Search for more papers by this authorCorresponding Author
Prof. Lele Li
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190 China
Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049 China
Search for more papers by this authorAbstract
Inspired by natural biomineralization processes, a simple and universal strategy is introduced to construct a biomimetic nanoplatform for systemic codelivery of a nucleic acid therapeutic (G3139) and a chemotherapeutic drug doxorubicin (DOX). This codelivery system was synthesized through one-pot supramolecular self-assembly of G3139, DOX, and FeII ions through multiple coordination interactions, followed by an adapted surface mineralization with metal–organic frameworks. The resulting core–shell nanoparticles have uniform size, well-defined nanosphere structure, robust colloidal stability, ultrahigh drug loading efficiency and capacity, and precisely adjustable ratios of two therapeutic agents. The system can efficiently accumulate in the tumor, allowing for sensitive MRI detection and synergistical inhibition of tumor growth without apparent systemic toxicity.
Supporting Information
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Filename | Description |
---|---|
ange201903417-sup-0001-misc_information.pdf1.6 MB | Supplementary |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1M. E. Gleave, B. P. Monia, Nat. Rev. Cancer 2005, 5, 468–479.
- 2O. Khorkova, C. Wahlestedt, Nat. Biotechnol. 2017, 35, 249–263.
- 3A. Wittrup, J. Lieberman, Nat. Rev. Genet. 2015, 16, 543–552.
- 4Y. Wang, S. Gao, W. H. Ye, H. S. Yoon, Y. Y. Yang, Nat. Mater. 2006, 5, 791–796.
- 5Y. Li, D. Maciel, J. Rodrigues, X. Shi, H. Tomás, Chem. Rev. 2015, 115, 8564–8608.
- 6H. Furukawa, K. E. Cordova, M. O'Keeffe, O. M. Yaghi, Science 2013, 341, 1230444.
- 7H. C. Zhou, J. R. Long, O. M. Yaghi, Chem. Rev. 2012, 112, 673–674.
- 8K. Lu, C. He, N. Guo, C. Chan, K. Ni, R. R. Weichselbaum, W. Lin, J. Am. Chem. Soc. 2016, 138, 12502–12510.
- 9Y. Ma, X. Li, A. Li, P. Yang, C. Zhang, B. Tang, Angew. Chem. Int. Ed. 2017, 56, 13752–13756; Angew. Chem. 2017, 129, 13940–13944.
- 10H. Zheng, Y. Zhang, L. Liu, W. Wan, P. Guo, A. M. Nyström, X. Zou, J. Am. Chem. Soc. 2016, 138, 962–968.
- 11M. H. Teplensky, M. Fantham, P. Li, T. C. Wang, J. P. Mehta, L. J. Young, P. Z. Moghadam, J. T. Hupp, O. K. Farha, C. F. Kaminski, D. Fairen-Jimenez, J. Am. Chem. Soc. 2017, 139, 7522–7532.
- 12R. Freund, U. Lachelt, T. Gruber, B. Rühle, S. Wuttke, ACS Nano 2018, 12, 2094–2105.
- 13S. Wuttke, M. Lismont, A. Escudero, B. Rungtaweevoranit, W. J. Parak, Biomaterials 2017, 123, 172–183.
- 14C. He, K. Lu, D. Liu, W. Lin, J. Am. Chem. Soc. 2014, 136, 5181–5184.
- 15K. Liang, R. Ricco, C. M. Doherty, M. J. Styles, S. Bell, N. Kirby, S. Mudie, D. Haylock, A. J. Hill, C. J. Doonan, P. Falcaro, Nat. Commun. 2015, 6, 7240–7248.
- 16H. Deng, S. Grunder, K. E. Cordova, C. Valente, H. Furukawa, M. Hmadeh, F. Gándara, A. C. Whalley, Z. Liu, S. Asahina, H. Kazumori, M. O'Keeffe, O. Terasaki, J. F. Stoddart, O. M. Yaghi, Science 2012, 336, 1018–1023.
- 17Y. Chen, P. Li, J. A. Modica, R. J. Drout, O. K. Farha, J. Am. Chem. Soc. 2018, 140, 5678–5681.
- 18D. Feng, T. F. Liu, J. Su, M. Bosch, Z. Wei, W. Wan, D. Yuan, Y. P. Chen, X. Wang, K. Wang, X. Lian, Z. Y. Gu, J. Park, X. Zou, H. C. Zhou, Nat. Commun. 2015, 6, 5979–5987.
- 19V. Lykourinou, Y. Chen, X. S. Wang, L. Meng, T. Hoang, L. J. Ming, R. L. Musselman, S. Ma, J. Am. Chem. Soc. 2011, 133, 10382–10385.
- 20G. Cheng, W. Li, L. Ha, X. Han, S. Hao, Y. Wan, Z. Wang, F. Dong, X. Zou, Y. Mao, S. Y. Zheng, J. Am. Chem. Soc. 2018, 140, 7282–7291.
- 21T. T. Chen, J. T. Yi, Y. Y. Zhao, X. Chu, J. Am. Chem. Soc. 2018, 140, 9912–9920.
- 22S. Li, M. Dharmarwardana, R. P. Welch, Y. Ren, C. M. Thompson, R. A. Smaldone, J. J. Gassensmith, Angew. Chem. Int. Ed. 2016, 55, 10691–10696; Angew. Chem. 2016, 128, 10849–10854.
- 23S. K. Alsaiari, S. Patil, M. Alyami, K. O. Alamoudi, F. A. Aleisa, J. S. Merzaban, M. Li, N. M. Khashab, J. Am. Chem. Soc. 2018, 140, 143–146.
- 24S. Wang, Y. Chen, S. Wang, P. Li, C. A. Mirkin, O. K. Farha, J. Am. Chem. Soc. 2019, 141, 2215–2219.
- 25M. Li, C. Wang, Z. Di, H. Li, J. Zhang, W. Xue, M. Zhao, K. Zhang, Y. Zhao, L. Li, Angew. Chem. Int. Ed. 2019, 58, 1350–1354; Angew. Chem. 2019, 131, 1364–1368.
- 26X. Tian, K. R. Lind, B. Yuan, S. Shaw, O. Siemianowski, L. Cademartiri, Adv. Mater. 2017, 29, 1604681.
- 27R. J. Klasa, A. M. Gillum, R. E. Klem, S. R. Frankel, Antisense Nucleic Acid Drug Dev. 2002, 12, 193–213.
- 28M. Peller, K. Böll, A. Zimpelb, S. Wuttke, Inorg. Chem. Front. 2018, 5, 1760–1779.
Citing Literature
This is the
German version
of Angewandte Chemie.
Note for articles published since 1962:
Do not cite this version alone.
Take me to the International Edition version with citable page numbers, DOI, and citation export.
We apologize for the inconvenience.